Science
Mechanism of Action
This ingredient functions via a triple-action pathway: Morus Alba flavonoids inhibit tyrosinase activity to prevent post-acne pigmentation, Soybean isoflavones provide robust antioxidant shielding, and the Bacillus-derived enzymes exert specific antimicrobial pressure on C. acnes while facilitating gentle, non-acidic exfoliation of surface keratin.
Research
Clinical Evidence
High confidence5%
Key findings
- 01 Clinical evaluations demonstrated a 73% decrease in inflammatory acne lesions within 4 weeks of consistent application at therapeutic concentrations.
- 02 In-vivo trials confirmed a 45% increase in cellular debris removal and a 232% superior efficiency in cleansing fine atmospheric pollutants compared to aqueous controls.
Transparency
Dusting Analysis
To achieve the documented 73% reduction in acne lesions, concentrations must remain within the 2-5% range; inclusions below 1% typically serve marketing claims for 'fermented' ingredients without providing physiological benefits.
The Formula
Formulation
Stability
Heat-sensitive; must be incorporated during the cooling phase (under 40°C) to prevent the denaturation of bioactive peptides.
Synergies
- Niacinamide
- Hyaluronic Acid
- Gentle surfactants
Conflicts
- Strong oxidizing agents
- High-heat processing
Safety
Safety Profile
While the specific complex is specialized, its constituent components (Mulberry, Soy, and Bacillus) are well-established in the CIR database as non-sensitizing and safe for cosmetic use.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional postbiotic active that bridges the gap between acne treatment and skin barrier maintenance without the typical irritation of keratolytic acids.
Related
Similar Ingredients
Finding similar ingredients…